Insider buying last 90 days
No open-market insider purchases were filed for CL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every CL insider filing, plotted on the chart in Gekko.Open CL in Gekko
NYSE: CL
Colgate-Palmolive (CL) Stock Analysis & Forecast
Nov 4 close
$98.76+3.14 (+3.3%)
Gekko Brief
AI summaryNov 4 closeColgate-Palmolive touched a 52-week high this week, with shares reaching $99.37 as investors sought stability in Dividend Kings like Colgate, Coca-Cola and Procter & Gamble following midterm election results. The move follows better-than-expected third-quarter 2026 earnings, with base business EPS exceeding expectations, emerging-market growth led by India, Brazil and China, and strength in Hill's Pet Nutrition, prompting several analyst firms to raise price targets. Separately, the company settled with the EPA for $930,000 over chemical reporting violations tied to imports at its Piscataway, New Jersey facility, stemming from a 2023 inspection.
Shares closed at $98.76, up 3.3%, sitting above both the 50-day average of $89.89 and the 200-day average of $89.87, with the 52-week range spanning $75.00 to $99.69. The GekkoIndex reads 48.3, placing the stock in the Neutral zone. Price remains 11.8% below Gekko Fair Value of $111.98.
The next earnings report is scheduled for 29 January 2027, 85 days out and beyond a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the current window, though one trailblazer holder is noted. Seasonality over the next 20 trading days has averaged a 2.7% gain across 5 years, rising in 4 of them. Analyst consensus among 12 firms stands at 8 buy and 4 hold ratings, with a consensus target of $101.70.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Colgate-Palmolive price vs fair value
Close $98.76200-day averageGekko Fair Value $111.98
Colgate-Palmolive quick facts
- Market cap
- $78.73B
- P/E ratio
- 37.1
- Forward P/E
- 23.3
- EPS, TTM
- $2.63
- Revenue, TTM
- $21.28B
- Profit margin
- 9.7%
- Dividend yield
- 2.20%
- Beta
- 0.31
- Volume
- 5.68M avg 4.93M
- 1-year return
- +31.7%
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±3.4%
- 50-day average
- $89.89
- 200-day average
- $89.87
- Next earnings
- Jan 29 before open
- Shares outstanding
- 794.9M
Colgate-Palmolive swing-trade checklist
Colgate-Palmolive scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
- Trendsupportive
Above 50 and 200-day
Close $98.76 is above the 50-day ($89.89) and 200-day ($89.87) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
48.3, Neutral
Reading 48.3 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
11.8% below
Price is 11.8% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 85 days
Next report Jan 29, 2027, 85 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+2.7% on average
From this point in the calendar, the next 20 trading days averaged +2.7% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Colgate-Palmolive stock chart and price history
Colgate-Palmolive closed at $98.76 on Nov 4, 2026, +31.7% over the past year, inside a 52-week range of $75.00 to $99.69.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +13.2%
- 3 months
- +6.2%
- 6 months
- +12.0%
- 1 year
- +31.7%
The full CL chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CL in Gekko
Follow Colgate-Palmolive through every session
Put CL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track CL in GekkoFree for 7 days. No credit card required.
About Colgate-Palmolive
Colgate-Palmolive makes and sells everyday consumer products worldwide, with a lineup that spans toothpaste, toothbrushes and mouthwash alongside soaps, shampoos, deodorants and skin care items, plus household staples like dishwashing liquid, fabric conditioner and cleaners. It is widely recognized for its oral care line sold under its own name, one of many brands in its portfolio that also includes Palmolive, Softsoap, Irish Spring, Speed Stick, Sanex, Fabuloso and Ajax, among others.
The business runs through two divisions. One covers oral, personal and home care goods, reaching consumers through retail stores, online channels, wholesalers and distributors, and also supplies dental professionals with specialized products. The other division, Pet Nutrition, produces everyday and therapeutic pet food under the Hill's Science Diet and Hill's Prescription Diet names, sold through pet supply retailers, veterinary offices and online platforms.
The company was established in 1806 and is headquartered in New York, New York. Its shares are listed on the NYSE under the ticker CL.
- Listed
- NYSE
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Website
- colgatepalmolive.com
Colgate-Palmolive GekkoIndex: the smart money zone
Colgate-Palmolive’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 48.3, in the Neutral zone, down 8.3 points over five sessions.
48.3Neutral
Down 8.3 points over five sessions.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 33 | +0.1% | +1.0% | ||
| Accumulation | 255 | +0.1% | +0.2% | ||
| Neutral (current zone) | 360 | +0.2% | +0.4% | ||
| Distribution | 46 | +0.2% | +1.6% | ||
| Selling | 3 | Too few readings yet | |||
Average CL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the CL price, zone by zone.Track CL in Gekko
Is Colgate-Palmolive stock overvalued? Gekko Fair Value
Colgate-Palmolive trades 11.8% below Gekko Fair Value of $111.98, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Colgate-Palmolive shares are worth, recalculated every trading day.
$111.98
Gekko Fair Value, Nov 4, 2026
11.8% Undervalued
At the end of Aug 2026 the price was 4.5% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open CL in Gekko
Colgate-Palmolive insider and Congress trading
No open-market insider purchases were filed for Colgate-Palmolive, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in CL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for CL, plotted on the chart in Gekko.Open CL in Gekko
Buybacks
Colgate-Palmolive has been buying back its own shares.
- Bought back, quarter ended Sep 30, 2026
- $597.0M
- As a share of market cap
- 0.76%
- Trailing four quarters
- $1.60B
From company filings.
Hedge funds and billionaires quarter ended Sep 30
1of the funds Gekko tracks holds CL.
0added1opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Colgate-Palmolive earnings: next date and track record
Colgate-Palmolive reports on Jan 29, 2027, before the open (85 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Jan 29, 2027
Expected before the open, 85 days away
- EPS estimate
- $0.97
- Revenue estimate
- $5.36B
7 of 8reports beat the EPS estimate
±2.9%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Oct 30, 2026 AI summary
- What they said
- Colgate-Palmolive delivered broad-based Q3 2026 organic sales growth across all four categories and four of five divisions, with base business EPS exceeding expectations. Emerging markets led growth (mid-single digits), driven by India, Brazil, and China, while Hill's business performed strongly. Free cash flow rose 7% with $2.2 billion returned to shareholders year-to-date. The company is scaling AI capabilities including PromoAI and investing in U.S. market share recovery.
- Guidance
- Management expressed optimism about long-term success but acknowledged near-term cost inflation remains elevated. Limited 2027 commentary was provided as planning is ongoing. The company remains committed to compounding EPS growth while sustaining advertising investment.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 30, 2026 | $0.97 est $0.93 | $5.37B est $5.34B | +4.6% |
| Jul 31, 2026 | $0.99 est $0.95 | $5.36B est $5.36B | −1.9% |
| May 1, 2026 | $0.80 est $0.95 | $5.32B est $5.22B | 0.0% |
| Jan 30, 2026 | $0.95 est $0.91 | $5.23B est $5.12B | +7.8% |
| Oct 31, 2025 | $0.91 est $0.89 | $5.13B est $5.13B | −2.0% |
| Aug 1, 2025 | $0.92 est $0.90 | $5.11B est $5.04B | −0.6% |
| Apr 25, 2025 | $0.91 est $0.86 | $4.91B est $4.87B | −1.9% |
| Jan 31, 2025 | $0.91 est $0.90 | $4.95B est $4.98B | −4.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Colgate-Palmolive stock forecast and analyst price targets
Analysts’ average 12-month price target for Colgate-Palmolive is $101.70, +3.0% from the last close, from 12 firms rating the stock in the last 90 days.
$101.70consensus 12-month target, +3.0% from the last close
Now $98.76Avg $101.70
Low $95High $112
Each firm’s latest rating in the last 90 days: 12 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 3 | Bernstein | $98 | −0.8% |
| Nov 3 | Barclays | $95 | −3.8% |
| Nov 2 | UBS | $112 | +13.4% |
| Nov 2 | Morgan Stanley | $111 | +12.4% |
| Nov 2 | TD Cowen | $97 | −1.8% |
+0.4%average 20-day move after past Neutral readings
+2.7%average move over the next 20 trading days in the last 5 years
±2.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Colgate-Palmolive seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Colgate-Palmolive averaged +2.7% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.1% | 4 of 5 |
| Next 10 trading days | +1.8% | 4 of 5 |
| Next 15 trading days | +2.7% | 4 of 5 |
| Next 20 trading days | +2.7% | 4 of 5 |
| Next 30 trading days | +4.3% | 4 of 5 |
For scale, CL’s typical 20-trading-day move in either direction is about 3.4%.
Colgate-Palmolive market cap and key statistics
Colgate-Palmolive’s market cap is $78.73B, with a P/E ratio of 37.1 and revenue of $21.28B over the last twelve months.
Valuation
- Market cap
- $78.73B
- P/E ratio
- 37.1
- Forward P/E
- 23.3
- EPS, TTM
- $2.63
- Gekko Fair Value
- $111.98
Trading
- Volume
- 5.68M
- Avg volume, 20 days
- 4.93M
- 52-week high
- $99.69
- 52-week low
- $75.00
- Shares outstanding
- 794.9M
Financials
- Revenue, TTM
- $21.28B
- Profit margin
- 9.7%
- Return on equity
- 231.7%
- Quarterly earnings growth, YoY
- +3.3%
Risk and income
- Beta
- 0.31
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±3.4%
- Dividend yield
- 2.20%
Colgate-Palmolive stock news this week
Coverage of Colgate-Palmolive this week reads positive: 14 positive, 2 neutral and 4 negative headlines.
- Colgate-Palmolive Settles With EPA Over Chemical ImportsWSJ, Nov 4
- Colgate-Palmolive Reaches $930,000 Settlement Over Chemical Reporting ViolationsEnvironmental Protection Online, Nov 4
- Here’s Why Dividend Kings Coca-Cola, Procter & Gamble, and Colgate-Palmolive Are Hitting 52-Week Highs Following Midterm Election ResultsThe Globe and Mail, Nov 4
- Colgate Palmolive stock hits 52-week high at 99.37 USDInvesting.com, Nov 4
- Colgate Palmolive stock hits 52-week high at 99.37 USD By Investing.comInvesting.com India, Nov 4
- Here's Why Dividend Kings Coca-Cola, Procter & Gamble, and Colgate-Palmolive Are Hitting 52-Week Highs Following Midterm Election ResultsThe Motley Fool, Nov 4
Colgate-Palmolive peers
Colgate-Palmolive’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGProcter & Gamble | Neutral | 11.0% below |
| ELEstee Lauder Companies | Neutral | 17.4% above |
| KVUEKenvue | Neutral | 15.5% below |
| KMBKimberly-Clark | Neutral | 10.8% below |
| CHDChurch & Dwight | Neutral | 4.6% above |
| CLXClorox | Distribution | 37.3% below |
A peer links to its own page where one exists.
Colgate-Palmolive stock FAQ
What is Colgate-Palmolive’s market cap?
Colgate-Palmolive’s market cap is $78.73B at the Nov 4, 2026 close of $98.76, with 794.9M shares outstanding. The shares trade on a P/E ratio of 37.1.
What is the Colgate-Palmolive stock forecast?
The consensus analyst 12-month price target for Colgate-Palmolive is $101.70, +3.0% from the last close. Of the 12 firms that rated the stock in the last 90 days, 8 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Colgate-Palmolive stock overvalued or undervalued?
On Gekko’s estimate Colgate-Palmolive is undervalued: the Nov 4, 2026 close of $98.76 is 11.8% below Gekko Fair Value of $111.98. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Colgate-Palmolive report earnings next?
Colgate-Palmolive is expected to report on Jan 29, 2027, before the market opens (85 days away). Analysts expect earnings of $0.97 per share on revenue of $5.36B. Colgate-Palmolive beat the earnings estimate in 7 of its last 8 reports, moving 2.9% on average across the report.
What is Colgate-Palmolive’s 52-week high and low?
Colgate-Palmolive’s 52-week high is $99.69 and its 52-week low is $75.00; it closed at $98.76 on Nov 4, 2026, +31.7% over the past year. Over the last five years the shares peaked at $109.30 on Sep 5, 2024.
Is Colgate-Palmolive stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (trend, fair value, earnings risk and seasonality), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Colgate-Palmolive the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.